| The effects of intravitreal ophthalmic medications on intraocular pressure. | |
| | |
MedLine Citation:
|
PMID: 19373694 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Ophthalmic medications are often given as intravitreal injection. Antimicrobials, antivirals, corticosteroids and anti- vascular endothelial growth factor agents are the main classes which can be administered through intravitreal injections. Possible complications of intravitreal injection include intraocular pressure changes, especially intraocular pressure elevations. This review discusses both injection-related intraocular pressure elevations which can occur immediately after injection of any kind of medication and drug specific-related intraocular pressure changes which may be detected days or even months after the injection. |
| | |
Authors:
|
Huijuan Wu; Teresa C Chen |
Related Documents
:
|
3177554 - Ab interno sclerostomy with a high-powered argon endolaser. 19951124 - Evaluation of the mydriatic effect of intracameral lidocaine hydrochloride injection in... 1427134 - The relationship between intraocular pressure and visual field progression in glaucoma. 281804 - Role of pituitary vasopressin in the formation and dynamics of aqueous humour. 17334254 - Pericontusional brain tissue exhibits persistent elevation of lactate/pyruvate ratio in... 10801394 - Whole-body systemic transcapillary filtration rates, coefficients, and isogravimetric c... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Seminars in ophthalmology Volume: 24 ISSN: 1744-5205 ISO Abbreviation: Semin Ophthalmol Publication Date: 2009 Mar-Apr |
Date Detail:
|
Created Date: 2009-04-17 Completed Date: 2009-05-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8610759 Medline TA: Semin Ophthalmol Country: United States |
Other Details:
|
Languages: eng Pagination: 100-5 Citation Subset: IM |
Affiliation:
|
Glaucoma Service, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiogenesis Inhibitors
/
administration & dosage,
adverse effects Antibodies, Monoclonal / administration & dosage, adverse effects Humans Injections / adverse effects Intraocular Pressure / drug effects* Ophthalmic Solutions / administration & dosage*, adverse effects* Vascular Endothelial Growth Factor A / antagonists & inhibitors Vitreous Body |
| Chemical | |
Reg. No./Substance:
|
0/Angiogenesis Inhibitors; 0/Antibodies, Monoclonal; 0/Ophthalmic Solutions; 0/Vascular Endothelial Growth Factor A; 0/bevacizumab; 0/ranibizumab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy.
Next Document: Neovascular glaucoma: etiology, diagnosis and prognosis.